Popular Stories

Therapeutics Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
On the Verge of commercialization with Odevixibat!

Albireo Pharma, Inc. (NASDAQ: ALBO) a clinical-stage company targeting rare liver diseases, announced the acceptance of its New Drug Application (NDA) for odevixibat, a once-daily, non-systemic IBAT, intended for the treatment of pruritus in patients with progressive familial intrahepatic cholestasis (PFIC). The candidate is also...

5 Biotech Stocks To Watch Out for in 2021

While Industries across the globe are grappling with the pandemic and its impact on their operations, Biotech Industry has been focused on minimizing the impact and marching ahead with its innovations and breakthroughs. We take a look at some Biotech’s that are impervious to the scare...

Can Novan Nitric Oxide Based Approach pay off in the long run?

Novan, Inc. (NASDAQ: NOVN), a clinical–stage Biotechnology Company leveraging its expertise in nitric oxide-based therapies, has entered into a Master Services Agreement (MSA) with Catalent for supporting the development and chemistry, manufacturing and control (CMC) activities for berdazimer sodium, to be made into an intranasal...

WordPress Video Lightbox Plugin